Bank of New York Mellon’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bank of New York Mellon’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-180,424	Closed	-$540K	–	4788
2022 Q1	$540K	Sell	180,424 -2,071,812	-92%	-$4.56M	﹤0.01%	3665
2021 Q4	$2.88M	Sell	2,252,236 -1,754,332	-44%	-$3.52M	﹤0.01%	2766
2021 Q3	$9.06M	Buy	4,006,568 +360,403	+10%	+$1.29M	﹤0.01%	2181
2021 Q2	$20.7M	Buy	3,646,165 +3,626,134	+18,103%	+$24.1M	﹤0.01%	1717
2021 Q1	$126K	Buy	+20,031	New	+$150K	﹤0.01%	4135

Bank of New York Mellon's TLMD Position: Q2 2022 in Review

Bank of New York Mellon sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 180,424 shares — an estimated $540K sold.

Bank of New York Mellon first reported a position in TLMD in Q1 2021 and held it in 5 quarters. The position peaked at $20.7M in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Bank of New York Mellon reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 180,424 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $540K.
Bank of New York Mellon first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Bank of New York Mellon's SOC Telemed, Inc. Class A Common Stock position peaked at $20.7M in Q2 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.